Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development
The thymus plays a fundamental role in establishing and maintaining central and peripheral tolerance and defects in thymic architecture or AIRE expression result in the development of autoreactive lymphocytes. Patients with partial DiGeorge Syndrome (pDGS) and Down Syndrome (DS) present alterations...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00447/full |
id |
doaj-a45773a2330e4a0eb3500a223a4c3747 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Genni Enza Marcovecchio Genni Enza Marcovecchio Ileana Bortolomai Ileana Bortolomai Francesca Ferrua Francesca Ferrua Francesca Ferrua Elena Fontana Elena Fontana Luisa Imberti Erika Conforti Donato Amodio Donato Amodio Sonia Bergante Giulia Macchiarulo Giulia Macchiarulo Veronica D'Oria Francesca Conti Silvia Di Cesare Georgia Fousteri Adriano Carotti Alessandro Giamberti Pietro Luigi Poliani Luigi D. Notarangelo Caterina Cancrini Caterina Cancrini Anna Villa Anna Villa Marita Bosticardo Marita Bosticardo |
spellingShingle |
Genni Enza Marcovecchio Genni Enza Marcovecchio Ileana Bortolomai Ileana Bortolomai Francesca Ferrua Francesca Ferrua Francesca Ferrua Elena Fontana Elena Fontana Luisa Imberti Erika Conforti Donato Amodio Donato Amodio Sonia Bergante Giulia Macchiarulo Giulia Macchiarulo Veronica D'Oria Francesca Conti Silvia Di Cesare Georgia Fousteri Adriano Carotti Alessandro Giamberti Pietro Luigi Poliani Luigi D. Notarangelo Caterina Cancrini Caterina Cancrini Anna Villa Anna Villa Marita Bosticardo Marita Bosticardo Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development Frontiers in Immunology thymus DiGeorge syndrome Down syndrome regulatory T (Treg) cells thymocytes |
author_facet |
Genni Enza Marcovecchio Genni Enza Marcovecchio Ileana Bortolomai Ileana Bortolomai Francesca Ferrua Francesca Ferrua Francesca Ferrua Elena Fontana Elena Fontana Luisa Imberti Erika Conforti Donato Amodio Donato Amodio Sonia Bergante Giulia Macchiarulo Giulia Macchiarulo Veronica D'Oria Francesca Conti Silvia Di Cesare Georgia Fousteri Adriano Carotti Alessandro Giamberti Pietro Luigi Poliani Luigi D. Notarangelo Caterina Cancrini Caterina Cancrini Anna Villa Anna Villa Marita Bosticardo Marita Bosticardo |
author_sort |
Genni Enza Marcovecchio |
title |
Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development |
title_short |
Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development |
title_full |
Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development |
title_fullStr |
Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development |
title_full_unstemmed |
Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development |
title_sort |
thymic epithelium abnormalities in digeorge and down syndrome patients contribute to dysregulation in t cell development |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2019-03-01 |
description |
The thymus plays a fundamental role in establishing and maintaining central and peripheral tolerance and defects in thymic architecture or AIRE expression result in the development of autoreactive lymphocytes. Patients with partial DiGeorge Syndrome (pDGS) and Down Syndrome (DS) present alterations in size and architecture of the thymus and higher risk to develop autoimmunity. We sought to evaluate thymic architecture and thymocyte development in DGS and DS patients and to determine the extent to which thymic defects result in immune dysregulation and T cell homeostasis perturbation in these patients. Thymi from pediatric patients and age-matched controls were obtained to evaluate cortex and medullary compartments, AIRE expression and thymocyte development. In the same patients we also characterized immunophenotype of peripheral T cells. Phenotypic and functional characterization of thymic and peripheral regulatory T (Treg) cells was finally assessed. Histologic analysis revealed peculiar alterations in thymic medulla size and maturation in DGS and DS patients. Perturbed distribution of thymocytes and altered thymic output was also observed. DGS patients showed lower mature CD4+ and CD8+ T cell frequency, associated with reduced proportion and function of Tregs both in thymus and peripheral blood. DS patients showed increased frequency of single positive (SP) thymocytes and thymic Treg cells. However, Tregs isolated both from thymus and peripheral blood of DS patients showed reduced suppressive ability. Our results provide novel insights on thymic defects associated with DGS and DS and their impact on peripheral immune dysregulation. Indeed, thymic abnormalities and defect in thymocyte development, in particular in Treg cell number and function could contribute in the pathogenesis of the immunodysregulation present in pDGS and in DS patients. |
topic |
thymus DiGeorge syndrome Down syndrome regulatory T (Treg) cells thymocytes |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2019.00447/full |
work_keys_str_mv |
AT gennienzamarcovecchio thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT gennienzamarcovecchio thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT ileanabortolomai thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT ileanabortolomai thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT francescaferrua thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT francescaferrua thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT francescaferrua thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT elenafontana thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT elenafontana thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT luisaimberti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT erikaconforti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT donatoamodio thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT donatoamodio thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT soniabergante thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT giuliamacchiarulo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT giuliamacchiarulo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT veronicadoria thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT francescaconti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT silviadicesare thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT georgiafousteri thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT adrianocarotti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT alessandrogiamberti thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT pietroluigipoliani thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT luigidnotarangelo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT caterinacancrini thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT caterinacancrini thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT annavilla thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT annavilla thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT maritabosticardo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment AT maritabosticardo thymicepitheliumabnormalitiesindigeorgeanddownsyndromepatientscontributetodysregulationintcelldevelopment |
_version_ |
1724890569947217920 |
spelling |
doaj-a45773a2330e4a0eb3500a223a4c37472020-11-25T02:16:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-03-011010.3389/fimmu.2019.00447417059Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell DevelopmentGenni Enza Marcovecchio0Genni Enza Marcovecchio1Ileana Bortolomai2Ileana Bortolomai3Francesca Ferrua4Francesca Ferrua5Francesca Ferrua6Elena Fontana7Elena Fontana8Luisa Imberti9Erika Conforti10Donato Amodio11Donato Amodio12Sonia Bergante13Giulia Macchiarulo14Giulia Macchiarulo15Veronica D'Oria16Francesca Conti17Silvia Di Cesare18Georgia Fousteri19Adriano Carotti20Alessandro Giamberti21Pietro Luigi Poliani22Luigi D. Notarangelo23Caterina Cancrini24Caterina Cancrini25Anna Villa26Anna Villa27Marita Bosticardo28Marita Bosticardo29Division of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyDivision of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyThe Milan Unit, Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Milan, ItalyDivision of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyVita-Salute San Raffaele University, Milan, ItalyPediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, ItalyThe Milan Unit, Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Milan, ItalyHumanitas Clinical and Research Center, Rozzano, Milan, ItalyLaboratorio CREA (Centro di Ricerca Emato-oncologica AIL), ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Pediatric Cardiac Surgery, IRCCS San Donato Milanese Hospital, San Donato Milanese, Milan, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyUniversity Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy0Laboratory of Stem Cells for Tissue Engineering, Istituto di Ricovero e Cura a Carattere Scientifico, Policlinico San Donato, Milan, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyUniversity Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDepartment of Pediatric Cardiac Surgery, IRCCS San Donato Milanese Hospital, San Donato Milanese, Milan, ItalyUniversity Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy1Division of Immunology Transplantation and Infectious Diseases, Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy2Department of Pediatric Cardiac Surgery, IRCCS Bambino Gesú Children's Hospital, Rome, Italy3Department of Congenital Cardiac Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy4Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy5Laboratory of Clinical Immunology and Microbiology, IDGS, DIR, NIAID, NIH, Bethesda, MD, United StatesDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyUniversity Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, ItalyDivision of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyThe Milan Unit, Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Milan, ItalyDivision of Regenerative Medicine, Stem Cells and Gene Therapy, Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy5Laboratory of Clinical Immunology and Microbiology, IDGS, DIR, NIAID, NIH, Bethesda, MD, United StatesThe thymus plays a fundamental role in establishing and maintaining central and peripheral tolerance and defects in thymic architecture or AIRE expression result in the development of autoreactive lymphocytes. Patients with partial DiGeorge Syndrome (pDGS) and Down Syndrome (DS) present alterations in size and architecture of the thymus and higher risk to develop autoimmunity. We sought to evaluate thymic architecture and thymocyte development in DGS and DS patients and to determine the extent to which thymic defects result in immune dysregulation and T cell homeostasis perturbation in these patients. Thymi from pediatric patients and age-matched controls were obtained to evaluate cortex and medullary compartments, AIRE expression and thymocyte development. In the same patients we also characterized immunophenotype of peripheral T cells. Phenotypic and functional characterization of thymic and peripheral regulatory T (Treg) cells was finally assessed. Histologic analysis revealed peculiar alterations in thymic medulla size and maturation in DGS and DS patients. Perturbed distribution of thymocytes and altered thymic output was also observed. DGS patients showed lower mature CD4+ and CD8+ T cell frequency, associated with reduced proportion and function of Tregs both in thymus and peripheral blood. DS patients showed increased frequency of single positive (SP) thymocytes and thymic Treg cells. However, Tregs isolated both from thymus and peripheral blood of DS patients showed reduced suppressive ability. Our results provide novel insights on thymic defects associated with DGS and DS and their impact on peripheral immune dysregulation. Indeed, thymic abnormalities and defect in thymocyte development, in particular in Treg cell number and function could contribute in the pathogenesis of the immunodysregulation present in pDGS and in DS patients.https://www.frontiersin.org/article/10.3389/fimmu.2019.00447/fullthymusDiGeorge syndromeDown syndromeregulatory T (Treg) cellsthymocytes |